WRIGHT TIMOTHY MICHAEL 4
4 · Regulus Therapeutics Inc. · Filed Jan 5, 2018
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-05+500,000→ 500,000 totalExercise: $1.24Exp: 2028-01-04→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.